European Medicines Agency approves Omicron booster vaccine

Vials of the Covid-19 vaccine
Vials of the Covid-19 vaccine Copyright Pfizer via AP
By Euronews with AP
Share this articleComments
Share this articleClose Button
Copy/paste the article video embed link below:Copy to clipboardCopied

The agency expects these vaccines to "help maintain optimal protection" against a continually evolving coronavirus


The European Medicines Agency has approved two booster vaccines against the Omicron variant of COVID-19 manufactured by drugmakers Pfizer/BioNTech and Moderna.

Following an extraordinary meeting at its headquarters in Amsterdam, the EMA explained that the adapted vaccines "can extend protection against different variants and are therefore expected to help maintain optimal protection" against COVID-19 as the virus evolves.

The vaccines "target the Omicron BA.1 sub-variant in addition to the original strain" of the coronavirus, the Amsterdam-based European Medicines Agency (EMA) said in a statement.

It's now up to the European Commission to approve the vaccines for the European market.

Globally, coronavirus cases and deaths have been dropping for weeks, but scientists expect a surge of hospitalisations and deaths with the coming onset of winter in the northern hemisphere. 

Watch the video above to find out more.

Share this articleComments

You might also like

UK becomes first country to approve Moderna's COVID vaccine that targets Omicron variant

COVID isn’t over. These are the Omicron subvariants still spreading and those of particular concern

European Medicines Agency the first to approve Moderna COVID-19 vaccine for children